Diagnosed atopic dermatitis, mild-to-moderate dermatitis symptoms in the facial and neck zones Skin and Connective Tissue Diseases Atopic dermatitis
Conditions
Interventions
52 subjects showing the clinical signs of dry skin, mild-to-moderate dermatitis symptoms and/or diagnosed atopic dermatitis in the facial and neck zones are enrolled. Subjects are asked to attend derm
Sponsors
Labrains SIA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients over the age of 18 years 2. Diagnosed atopic dermatitis and/or mild-to-moderate dermatitis symptoms in the facial and neck zones 3. Has not been recently involved in any other similar study 4. Willingness to use during all the study period only the product to be tested in the facial and neck zones 5. Willingness to not vary the normal daily routine
Exclusion criteria
Exclusion criteria: 1. Pregnancy 2. Scars, open lesions and wounds at the product application site 3. Allergy to any of the components of the study drug 4. The study protocol is not followed
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Severity of skin condition in the dimension of skin sensations, measured by a Likert scale from 0 - no feeling to 5 - acute or severe in four dimensions (sting sensation/tingling; burning/heat sensation; heat wave; skin irritation/discomfort/sensitivity) at baseline and 28 days 2. Severity of skin condition in the dimension of visible skin changes, measured by a Likert scale from 0 - no symptoms to 5 - acute or severe in four dimensions (diffuse redness/flushing; extended vascular networking; rash; edema/swelling) at baseline and 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin visual appeal and overall participant quality of life changes associated with the symptoms of dermatitis assessed during the discussion and observations of a dermatologist at baseline and 28 days | — |
Countries
Latvia
Contacts
Public ContactAleksandra Kozlova
Outcome results
None listed